The article argues that U.S. vaccine confidence requires an independent National Vaccine Safety Board, expanded real-world surveillance, public-responsive research, and genomic studies to distinguish causal adverse events, identify vulnerable individuals, and improve vaccine safety and trust.
No takes yet. Share an insight, caveat, or question.
Salmon et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: